ArticleCureus2025

Clinical Oncological Tolerance of Testosterone Replacement Therapy Over Two Years Among Patients With High-Risk or Very High-Risk Prostate Cancer Undergoing Radiotherapy.

Kazuyoshi Shigehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.